Group One Trading, L.P. Meridian Bioscience Inc Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $107,223 - $139,050	-6,180 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$18.01 - $28.32 $285,224 - $448,503	-15,837 Reduced 71.93%	6,180 $137,000
Q1 2021 May 12, 2021	SELL	$19.76 - $29.89 $467,600 - $707,316	-23,664 Reduced 51.8%	22,017 $578,000
Q4 2020 Feb 10, 2021	SELL	$15.73 - $21.66 $248,958 - $342,812	-15,827 Reduced 25.73%	45,681 $854,000
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $809,678 - $1.58 Million	59,799 Added 3499.06%	61,508 $1.04 Million
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $13,398 - $39,802	1,709 New	1,709 $40,000
Q1 2020 May 13, 2020	SELL	$5.57 - $11.5 $557 - $1,150	-100 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$10.88 - $17.6 $1,088 - $1,760	100 New	100 $1,000
Q3 2017 Nov 15, 2017	SELL	$13.45 - $14.35 $1,304 - $1,391	-97 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	97	97 $2,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.